EMEA STARTS ASSESSING COMPASSIONATE USE OF UNAUTHORISED MEDICINES
February 1st, 2010
BY KEITH NUTHALL
ASSESSMENTS are under way by the European Medicines Agency (EMEA) of European Union (EU) government plans to allow compassionate use of medicines yet to receive full market authorisation. EMEA has released its first such assessment - of a Finland policy to allow the use of the new Tamiflu IV. The agency said this should only be considered "to treat critically ill adults and children older than 1 year of age having a life-threatening condition" due to H1N1 or seasonal flu virus, where other drugs are failing. EMEA will publish a series ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.